Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rationale design, synthesis, cytotoxicity evaluation, andin silicomechanistic studies of novel 1,2,3-triazoles with potential anticancer activity
Esraa M. Othman, Eman A. Fayed, Ebtehal M. Husseiny, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 25, pp. 12206-12216
Closed Access | Times Cited: 28

Showing 1-25 of 28 citing articles:

In vitroand computational investigations of novel synthetic carboxamide-linked pyridopyrrolopyrimidines with potent activity as SARS-CoV-2-MProinhibitors
Ateyatallah Aljuhani, Hany E. A. Ahmed, Saleh Ihmaid, et al.
RSC Advances (2022) Vol. 12, Iss. 41, pp. 26895-26907
Open Access | Times Cited: 39
Phenylpyrazolone-1,2,3-triazole Hybrids as Potent Antiviral Agents with Promising SARS-CoV-2 Main Protease Inhibition Potential
Arafa Musa, Hamada S. Abulkhair, Ateyatallah Aljuhani, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 3, pp. 463-463
Open Access | Times Cited: 33
Recent advances in triazoles as tyrosinase inhibitors
Arif Mermer, Serpil Demirci
European Journal of Medicinal Chemistry (2023) Vol. 259, pp. 115655-115655
Closed Access | Times Cited: 33
Fluorinated indeno-quinoxaline bearing thiazole moieties as hypoglycaemic agents targeting α -amylase, and α -glucosidase: synthesis, molecular docking, and ADMET studies
Nirvana A. Gohar, Eman A. Fayed, Yousry A. Ammar, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 8
Biological activity of copper porphyrins
Athulya Das, Thasnim P Mohammed, Muniyandi Sankaralingam
Coordination Chemistry Reviews (2024) Vol. 506, pp. 215661-215661
Closed Access | Times Cited: 7
Novel isatin–triazole based thiosemicarbazones as potential anticancer agents: synthesis, DFT and molecular docking studies
Alia Mushtaq, Rabbia Asif, Waqar Ahmed Humayun, et al.
RSC Advances (2024) Vol. 14, Iss. 20, pp. 14051-14067
Open Access | Times Cited: 7
Exploring 1,2,3-triazole-Schiff’s base hybrids as innovative EGFR inhibitors for the treatment of breast cancer: In vitro and in silico study
Nareman A. Nawareg, Asmaa S. A. Yassen, Ebtehal M. Husseiny, et al.
Bioorganic Chemistry (2025) Vol. 155, pp. 108106-108106
Closed Access
The effect of novel synthetic semicarbazone- and thiosemicarbazone-linked 1,2,3-triazoles on the apoptotic markers, VEGFR-2, and cell cycle of myeloid leukemia
Esraa M. Othman, Eman A. Fayed, Ebtehal M. Husseiny, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105968-105968
Closed Access | Times Cited: 30
The anticancer and EGFR-TK/CDK-9 dual inhibitory potentials of new synthetic pyranopyrazole and pyrazolone derivatives: X-ray crystallography, in vitro , and in silico mechanistic investigations
Arafa Musa, Saleh Ihmaid, David L. Hughes, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 21, pp. 12411-12425
Open Access | Times Cited: 17
Exploring the cytotoxic effect and CDK-9 inhibition potential of novel sulfaguanidine-based azopyrazolidine-3,5-diones and 3,5-diaminoazopyrazoles
Ebtehal M. Husseiny, Hamada S. Abulkhair, Nehad M. El‐Dydamony, et al.
Bioorganic Chemistry (2023) Vol. 133, pp. 106397-106397
Closed Access | Times Cited: 16
In-silico identification of small molecule benzofuran-1,2,3-triazole hybrids as potential inhibitors targeting EGFR in lung cancer via ligand-based pharmacophore modeling and molecular docking studies
Sunil Kumar, Iqra Ali, Faheem Abbas, et al.
In Silico Pharmacology (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 16
A novel class of phenylpyrazolone-sulphonamides rigid synthetic anticancer molecules selectively inhibit the isoform IX of carbonic anhydrases guided by molecular docking and orbital analyses
Maan T. Khayat, Hany E. A. Ahmed, Abdelsattar M. Omar, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 24, pp. 15243-15261
Closed Access | Times Cited: 14
Structure-based development of 3,5-dihydroxybenzoyl-hydrazineylidene as tyrosinase inhibitor; in vitro and in silico study
Azzam Bagheri, Shahram Moradi, Aida Iraji, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 4
Fluorinated thiazole–thiosemicarbazones hybrids as potential PPAR-γ agonist and α-amylase, α-glucosidase antagonists: Design, synthesis, in silico ADMET and docking studies and hypoglycemic evaluation
Eman A. Fayed, A. Ben Thabet, Shimaa M. Abd El‐Gilil, et al.
Journal of Molecular Structure (2023) Vol. 1301, pp. 137374-137374
Closed Access | Times Cited: 11
Exploring the dual effect of novel 1,4-diarylpyranopyrazoles as antiviral and anti-inflammatory for the management of SARS-CoV-2 and associated inflammatory symptoms
Azizah M. Malebari, Hany E. A. Ahmed, Saleh Ihmaid, et al.
Bioorganic Chemistry (2022) Vol. 130, pp. 106255-106255
Open Access | Times Cited: 18
An alternative technique for cyclization synthesis, in vitro anti-esophageal cancer evaluation, and molecular docking of novel thiazolidin-4-one derivatives
Ahmed Majeed Jassem, Adil Muala Dhumad, Jinan Khudhair Salim, et al.
Journal of Molecular Structure (2023) Vol. 1280, pp. 135079-135079
Closed Access | Times Cited: 8
Novel benzochromenes: design, synthesis, cytotoxicity, molecular docking and mechanistic investigations
Fatma G. Abdulrahman, Hamada S. Abulkhair, Riham A. Zidan, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 2, pp. 105-123
Closed Access | Times Cited: 2
Novel imidazolone derivatives as potential dual inhibitors of checkpoint kinases 1 and 2: Design, synthesis, cytotoxicity evaluation, and mechanistic insights
Yasmin S. Sheta, Marwa T. Sarg, Fatma G. Abdulrahman, et al.
Bioorganic Chemistry (2024) Vol. 149, pp. 107471-107471
Closed Access | Times Cited: 2
In vivo evaluation of novel synthetic pyrazolones as CDK9 inhibitors with enhanced pharmacokinetic properties
Ebtehal M. Husseiny, Hamada S. Abulkhair, Samiha A. El‐Sebaey, et al.
Future Medicinal Chemistry (2024), pp. 1-19
Closed Access | Times Cited: 2
Thiocarbohydrazone and Chalcone-Derived 3,4-Dihydropyrimidinethione as Lipid Peroxidation and Soybean Lipoxygenase Inhibitors
Nikitas Georgiou, Eleni Chontzopoulou, Antigoni Cheilari, et al.
ACS Omega (2023) Vol. 8, Iss. 13, pp. 11966-11977
Open Access | Times Cited: 7
Design and Synthesis of Novel Uracil-Linked Schiff Bases As Dual Histone Deacetylase Type II/topoisomerase Type I Inhibitors With Apoptotic Potential
Samar El‐Kalyoubi, Samar S. Elbaramawi, Ahmed G. Eissa, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 11, pp. 937-958
Closed Access | Times Cited: 7
Pyrano-coumarin hybrids as potential antimicrobial agents against MRSA strains: Design, synthesis, ADMET, molecular docking studies, as DNA gyrase inhibitors
Eman A. Fayed, Maha A. Ebrahim, Usama Fathy, et al.
Journal of Molecular Structure (2023) Vol. 1295, pp. 136663-136663
Closed Access | Times Cited: 7
Aminopyridone-linked benzimidazoles: a fragment-based drug design for the development of CDK9 inhibitors
Ebtehal M. Husseiny, Hamada S. Abulkhair, Sanadelaslam SA El-Hddad, et al.
Future Medicinal Chemistry (2023) Vol. 15, Iss. 14, pp. 1213-1232
Closed Access | Times Cited: 4
Molecular overlay-guided design of new CDK2 inhibitor thiazepinopurines: Synthesis, anticancer, and mechanistic investigations
Ebtehal M. Husseiny, Hamada S. Abulkhair, Asmaa Saleh, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106789-106789
Closed Access | Times Cited: 4
Design, synthesis, characterization and biological evaluation of coumarin bound 1,2,3-triazoles using click chemistry
Jyoti Yadav, C.P. Kaushik, Munish Ahuja, et al.
Synthetic Communications (2024), pp. 1-20
Closed Access
Page 1 - Next Page

Scroll to top